About Lexitas
Lexitas is a Healthcare company based in Durham (United States) founded in 2011 by Chad Ice and George Magrath, and was acquired by QHP Capital in July 2022. Clinical trials and medical strategies for ophthalmology products are provided. It operates on a Professional Services and HealthTech model. The company has 106 employees. Lexitas offers products and services including Ophthalmology Clinical Research and Reading Center Services. Its focus areas include Biotechnology and Clinical Research Organizations. Its legal entity is Lexitas Pharma Services, Inc. Its competitors include EyeCRO, Humonix Biosciences and Optimal Tracers.
Company details
Lexitas is established as a clinical research organization with over 14 years of exclusive focus on ophthalmology. Services are provided across all ophthalmic subspecialties, ensuring tailored approaches and rigorous quality standards. End-to-end guidance is offered through every stage of clinical development. The team, comprising ophthalmologists, optometrists, and imaging experts, brings over 475 years of combined experience. Personalized services are designed to meet specific protocol and project needs. Operational success is prioritized for sponsors and clinical sites in the healthcare sector.
- Headquarters Durham, United States
- Employees 106
- Founders Chad Ice, George Magrath
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website lexitas.com
- Social LinkedIn X Facebook
- Acquired by QHP Capital (Jul 2022)
- Legal Name Lexitas Pharma Services, Inc.
- Investors
- Employee Count106
- Acquired byQHP Capital
(Jul 2022)
Products & Services of Lexitas
Lexitas offers a comprehensive portfolio of products and services, including Ophthalmology Clinical Research and Reading Center Services.
Specialized clinical research services for ophthalmology are provided.
Support for clinical trials through imaging expertise is offered.
Investors in Lexitas
Lexitas has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include QHP Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Capital is provided to build leading healthcare companies. | qhpcapital.com | Research Triangle Park, United States |
Investor details for Lexitas
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lexitas
2 people are tracked at Lexitas (2 in leadership); the tracked headcount is 106.
| Name | Role | Group |
|---|---|---|
Chad Ice | Co-Founder | Leadership |
George Magrath | Co-Founder | Leadership |
Complete people profiles for Lexitas
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lexitas
2 dated milestones of Lexitas across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Lexitas is founded.
- Exit Acquired by QHP Capital.
Competitors of Lexitas
Lexitas has 3 listed competitors in our database. They include EyeCRO, Humonix Biosciences and Optimal Tracers.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eyecro.com | 2011 | Oklahoma, United States | Provider of in vivo and in vitro models for ophthalmic research | |||
| humonixbio.com | 2014 | Albany, United States | CRO focused on ophthalmic drugs development services | |||
| optimaltracers.org | 2013 | Sacramento, United States | CRO focused on clinical research and tracer development services |
Detailed competitors of Lexitas
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lexitas
The website of Lexitas (lexitas.com) receives about 4.9K visits a month.
- Monthly visits4.9K
▲ 12.5% vs previous month
Websites whose visitors overlap most with Lexitas. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| qhpcapital.com | 100% | #4,330,266 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Lexitas (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lexitas
Lexitas was founded in 2011.
Lexitas is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Lexitas has 106 employees.
Lexitas is established as a clinical research organization with over 14 years of exclusive focus on ophthalmology. Services are provided across all ophthalmic subspecialties, ensuring tailored approaches and rigorous quality standards. End-to-end guidance is offered through every stage of clinical development. The team, comprising ophthalmologists, optometrists, and imaging experts, brings over 475 years of combined experience. Personalized services are designed to meet specific protocol and project needs. Operational success is prioritized for sponsors and clinical sites in the healthcare sector.
Lexitas's top competitors include Humonix Biosciences, EyeCRO and Optimal Tracers.
Lexitas offers Ophthalmology Clinical Research and Reading Center Services.
Lexitas has 1 investor. Key investors include QHP Capital.
Lexitas operates through Lexitas Pharma Services, Inc..
Yes. Lexitas was acquired by QHP Capital in July 2022.